United Therapeutics Corp
UTHRCIK 0001082554 · last filing Jul 8, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
55,800 bought / 55,800 sold
net +0 sh · −$23.04M
- buys
- 6
- sells
- 60
- insiders active
- 2
Filing tape
Filed Wed, Jul 8, 2026
- −0 sh · $4.02M
Rothblatt Martine A — Chairperson & CEO · Director
- Exercised9,500Common Stock@ $135.42→ 50,013 held
- Sold200Common Stock@ $553.12→ 49,813 held
- Sold241Common Stock@ $554.36→ 49,572 held
- Sold596Common Stock@ $555.50→ 48,976 held
- Sold726Common Stock@ $556.55→ 48,250 held
- Sold1,096Common Stock@ $557.78→ 47,154 held
- Sold1,875Common Stock@ $558.90→ 45,279 held
- Sold3,399Common Stock@ $559.76→ 41,880 held
- Sold505Common Stock@ $560.49→ 41,375 held
- Sold800Common Stock@ $562.60→ 40,575 held
- Sold62Common Stock@ $563.24→ 40,513 held
- Exercised9,500Stock Option→ 49,218 held
Filed Tue, Jul 7, 2026
- −0 sh · $3.93M
Rothblatt Martine A — Chairperson & CEO · Director
- Exercised9,500Common Stock@ $135.42→ 50,013 held
- Sold2,098Common Stock@ $546.93→ 47,915 held
- Sold1,031Common Stock@ $548.00→ 46,884 held
- Sold3,354Common Stock@ $549.03→ 43,530 held
- Sold2,116Common Stock@ $549.87→ 41,414 held
- Sold329Common Stock@ $550.78→ 41,085 held
- Sold131Common Stock@ $551.88→ 40,954 held
- Sold135Common Stock@ $553.39→ 40,819 held
- Sold306Common Stock@ $553.90→ 40,513 held
- Exercised9,500Stock Option→ 58,718 held
Filed Thu, Jul 2, 2026
- −0 sh · $3.37M
Mahon Paul A — EVP & GENERAL COUNSEL
- Exercised8,300Common Stock@ $146.03→ 53,472 held
- Sold658Common Stock@ $548.00→ 52,814 held
- Sold258Common Stock@ $548.73→ 52,556 held
- Sold384Common Stock@ $550.02→ 52,172 held
- Sold1,467Common Stock@ $551.30→ 50,705 held
- Sold1,818Common Stock@ $552.61→ 48,887 held
- Sold2,201Common Stock@ $553.52→ 46,686 held
- Sold299Common Stock@ $554.45→ 46,387 held
- Sold990Common Stock@ $555.83→ 45,397 held
- Sold225Common Stock@ $556.36→ 45,172 held
- Exercised8,300Stock Option→ 89,040 held
- −0 sh · $3.98M
Rothblatt Martine A — Chairperson & CEO · Director
- Exercised9,500Common Stock@ $135.42→ 50,013 held
- Sold192Common Stock@ $548.01→ 49,821 held
- Sold130Common Stock@ $548.75→ 49,691 held
- Sold118Common Stock@ $549.77→ 49,573 held
- Sold640Common Stock@ $551.59→ 48,933 held
- Sold993Common Stock@ $552.72→ 47,940 held
- Sold776Common Stock@ $553.64→ 47,164 held
- Sold2,006Common Stock@ $554.75→ 45,158 held
- Sold2,942Common Stock@ $555.67→ 42,216 held
- Sold1,343Common Stock@ $556.56→ 40,873 held
- Sold320Common Stock@ $557.63→ 40,553 held
- Sold40Common Stock@ $558.37→ 40,513 held
- Exercised9,500Stock Option→ 68,218 held
- −0 sh · $3.88M
Rothblatt Martine A — Chairperson & CEO · Director
- Exercised9,500Common Stock@ $135.42→ 50,013 held
- Sold405Common Stock@ $537.58→ 49,608 held
- Sold818Common Stock@ $539.09→ 48,790 held
- Sold1,524Common Stock@ $539.92→ 47,266 held
- Sold773Common Stock@ $540.92→ 46,493 held
- Sold880Common Stock@ $542.15→ 45,613 held
- Sold520Common Stock@ $543.16→ 45,093 held
- Sold880Common Stock@ $545.00→ 44,213 held
- Sold1,124Common Stock@ $546.46→ 43,089 held
- Sold969Common Stock@ $547.40→ 42,120 held
- Sold1,221Common Stock@ $548.21→ 40,899 held
- Sold386Common Stock@ $549.14→ 40,513 held
- Exercised9,500Stock Option→ 77,718 held
Filed Wed, Jul 1, 2026
- −0 sh · $3.85M
Rothblatt Martine A — Chairperson & CEO · Director
- Exercised9,500Common Stock@ $135.42→ 50,013 held
- Sold110Common Stock@ $536.28→ 49,903 held
- Sold518Common Stock@ $537.75→ 49,385 held
- Sold988Common Stock@ $538.51→ 48,397 held
- Sold1,309Common Stock@ $539.93→ 47,088 held
- Sold2,235Common Stock@ $540.76→ 44,853 held
- Sold2,499Common Stock@ $541.60→ 42,354 held
- Sold1,081Common Stock@ $542.62→ 41,273 held
- Sold440Common Stock@ $543.30→ 40,833 held
- Sold66Common Stock@ $545.96→ 40,767 held
- Sold14Common Stock@ $546.60→ 40,753 held
- Sold240Common Stock@ $549.27→ 40,513 held
- Exercised9,500Stock Option→ 87,218 held
Insiders on this tape
- Rothblatt Martine AChairperson & CEO · Director
- Mahon Paul AEVP & GENERAL COUNSEL
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.